Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis, IGA”

279 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 279 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT06528015
What this trial is testing

Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAProbioticsBudesonide
Gang Xu 206
Very early researchWithdrawnNCT06926985
What this trial is testing

An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Jieyang People's Hospital
Testing effectiveness (Phase 2)Study completedNCT04014335
What this trial is testing

Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Ionis Pharmaceuticals, Inc. 23
Not applicableUnknownNCT00378443
What this trial is testing

ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT

Who this might be right for
Glomerulonephritis, IGA
Peking University
Large-scale testing (Phase 3)Ended earlyNCT00318474
What this trial is testing

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy

Who this might be right for
IgA Nephropathy
St. Joseph's Hospital and Medical Center, Phoenix 184
Large-scale testing (Phase 3)Active Not RecruitingNCT06291376
What this trial is testing

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A NephropathyIgAN
Alexion Pharmaceuticals, Inc. 579
Large-scale testing (Phase 3)Not Yet RecruitingNCT07807995
What this trial is testing

Open-Label Study of Long-term Treatment With Povetacicept in Adults With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy
Vertex Pharmaceuticals Incorporated 605
Testing effectiveness (Phase 2)Active Not RecruitingNCT05687890
What this trial is testing

Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseIgA Nephropathy
Biocity Biopharmaceutics Co., Ltd. 255
Not applicableStudy completedNCT01538433
What this trial is testing

A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 603
Large-scale testing (Phase 3)Active Not RecruitingNCT05852938
What this trial is testing

Zigakibart in Adults With IgA Nephropathy

Who this might be right for
IgA NephropathyImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 383
Testing effectiveness (Phase 2)UnknownNCT02160132
What this trial is testing

A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.

Who this might be right for
Glomerulonephritis, IGAPeripapillary CrescentNecrosis+1 more
Sun Yat-sen University 180
Very early researchLooking for participantsNCT07507201
What this trial is testing

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Post-approval studies (Phase 4)Looking for participantsNCT07604311
What this trial is testing

Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Nanfang Hospital, Southern Medical University 288
Testing effectiveness (Phase 2)Ended earlyNCT02682407
What this trial is testing

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Who this might be right for
IgANLNMN+1 more
Omeros Corporation 31
Not applicableLooking for participantsNCT05234463
What this trial is testing

Study of the Link Between Complement Activation and IgA Nephropathy Severity

Who this might be right for
IgA Nephropathy Severity in Kidney Transplantation
University Hospital, Strasbourg, France 400
Not applicableNot Yet RecruitingNCT07481084
What this trial is testing

IgA Nephropathy Insights From Treatment Experience Among Patients Receiving Iptacopan and/or Atrasentan Using Primary Data Collection

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 80
Large-scale testing (Phase 3)Study completedNCT05534919
What this trial is testing

Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301

Who this might be right for
Primary Immunoglobulin a Nephropathy (IgAN)
Everest Medicines (Singapore) Pte. Ltd. 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05517980
What this trial is testing

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

Who this might be right for
Glomerulonephritis
Kira Pharmacenticals (US), LLC. 52
Testing effectiveness (Phase 2)Ended earlyNCT05162066
What this trial is testing

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Who this might be right for
Complement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy
BioCryst Pharmaceuticals 2
Not applicableUnknownNCT01126931
What this trial is testing

Wormwood in Chronic Progressive Disorders With Reduced Appetite

Who this might be right for
Cancer
University Hospital Freiburg 300
Next Page